Indivior Pharmaceuticals, Inc.

INDV · Nasdaq · SIC 2834: Pharmaceutical Preparations
371
SEC Filings

Business Summary

PART I . Overview Indivior Pharmaceuticals, Inc. and its subsidiaries (together, "Indivior" or the "Company") is the market leader in long-acting injectable medications for opioid use disorder (OUD). Indivior is focused on delivering evidence-based pharmacotherapies for OUD and is committed to advancing the neurobiological understanding of OUD as a chronic, relapsing, but treatable brain disease. For more than 25 years, Indivior has led innovation in addiction medicine, developing differentiated...

Next Earnings

Q2 FY2026 — expected 2026-09-27

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionINDVdiscussed_in_filing Cybersecurity
topic_mentionINDVdiscussed_in_filing Trusted Computing
topic_mentionINDVdiscussed_in_filing Blockchain & Crypto
topic_mentionINDVdiscussed_in_filing Supply Chain
topic_mentionINDVdiscussed_in_filing Regulation
topic_mentionINDVdiscussed_in_filing Healthcare & Bio
topic_mentionINDVdiscussed_in_filing Sovereign & Government
topic_mentionINDVdiscussed_in_filing Cybersecurity
topic_mentionINDVdiscussed_in_filing Trusted Computing
topic_mentionINDVdiscussed_in_filing Blockchain & Crypto
topic_mentionINDVdiscussed_in_filing Supply Chain
topic_mentionINDVdiscussed_in_filing Regulation
topic_mentionINDVdiscussed_in_filing Healthcare & Bio
topic_mentionINDVdiscussed_in_filing Sovereign & Government
topic_mentionINDVdiscussed_in_filing Cybersecurity
topic_mentionINDVdiscussed_in_filing Trusted Computing
topic_mentionINDVdiscussed_in_filing Blockchain & Crypto
topic_mentionINDVdiscussed_in_filing Supply Chain
topic_mentionINDVdiscussed_in_filing Regulation
topic_mentionINDVdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012237EDGAR82K words
2025-03-032024-12-310001625297-25-000016EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001628280-25-047530EDGAR16K words
2025-07-312025-06-300001625297-25-000050EDGAR—
2025-05-012025-03-310001625297-25-000030EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001625297-26-000015EDGAR45K words
2026-03-130001625297-26-000012EDGAR—
2026-03-120001625297-26-000008EDGAR—
2026-02-260001193125-26-073363EDGAR—
2026-01-260001193125-26-021660EDGAR—
2026-01-080001193125-26-006993EDGAR—
2025-12-220001625297-25-000078EDGAR—
2025-12-180001625297-25-000076EDGAR—
2025-12-150001625297-25-000072EDGAR—
2025-11-200001625297-25-000069EDGAR—

371 total filings indexed. 356 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001625297
TickerINDV
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c3656e686714adbe1038fda86e2652579f1cac2d436a4e64af36fa4bce2b9582
parent: 6a0b7d83b01ccac4e4a5ddee039c9fe425940eac51c25fd67b0191777c4b274d
content hash: 00952a250c2633f2e110b3e70c23c8bb049807287aed89842a0702aa68f1f960
signed: 2026-04-13T04:45:41.571Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf